Sign inJoin waitlistJoin the waitlist

Sundar Jagannath

Medical Oncology · Icahn School of Medicine at Mount Sinai

Credentials: · · · ·

History

Bronx-Lebanon Hospital Center
BronxCare Hospital Center
Wayne State University
University of Texas MD Anderson Cancer Center
University of Baroda

Research

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Review · The Lancet Oncology · 2014 · 3,783 citations
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
Review · The Lancet Oncology · 2016 · 2,602 citations
A phase 2 study of bortezomib in relapsed, refractory myeloma
New England Journal of Medicine · 2003 · 2,206 citations

BB
Bart Barlogie
83 papers
Ajai Chari
78 papers
Samir Parekh
72 papers
David Siegel
71 papers
David Vesole
67 papers
Paul Richardson
57 papers
Joshua Richter
51 papers
Ken Anderson
51 papers
Guido Tricot
49 papers
Hearn Cho
48 papers
Sagar Lonial
47 papers
Nikhil Munshi
44 papers

Clinical trials

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma
Principal investigator · Withdrawn · Phase 1
Piramal Enterprises Limited
2008–2010
Study of TBL 12 Sea Cucumber Extract for Patients With Untreated Asymptomatic Myeloma
Principal investigator · Terminated · Phase 2
Jagannath, Sundar, M.D.
2008–2014
A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma
Principal investigator · Completed · Phase 2
Incyte Corporation
2008–2010
An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma
Principal investigator · Completed · Phase 1
Innate Pharma
2007–2011